Vivanza Biosciences reschedules board meeting to August 7th to review quarterly financials Back

Vivanza Biosciences Limited informed the BSE Limited that a meeting of the Board of Directors has been rescheduled to Friday, August 07th, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with a limited review report, and to address other matters including a notice of disclosure of interest and declarations from independent directors.